Spots Global Cancer Trial Database for unresectable stage iii nsclc
Every month we try and update this database with for unresectable stage iii nsclc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC | NCT04161352 | Unresectable St... | 18 Years - 75 Years | Zhejiang Cancer Hospital | ||
Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidation Only in Addition to Standard Chemoradiotherapy in Unresectable Stage III NSCLC Patients (PASTURE) | NCT03945227 | Stage III NSCLC | standard platin... PDR001 concurre... | 18 Years - | Yonsei University | |
Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. | NCT04381494 | Unresectable St... | Multiparametric... | 18 Years - 130 Years | AstraZeneca |